In market activity today, Knight Therapeutics Inc shares closed at $5.44 after opening the day at $5.43. It traded at a low of $5.35 to a high of $5.46.

Share prices advanced 0.18 percent from the previous day's close of $5.43.

Today across North America, the TSX Composite closed -0.14% at 21912.52, the S&P 500 closed -0.28% at 5203.58, the Dow Jones Industrial Average closed -0.08% at 39282.33 and the Nasdaq Composite closed -0.42% at 16315.70.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

Trading volume was 28,577 on 225 total trades, while having an average volume of 169,096 over the last 5-days.

The TSX overall saw 3,990 price advancers against 1,258 declines and 113 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.75 (January 22,2024) and low as $4.28 (March 28,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have raised 25.06 percent, while they have raised 4.82% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $549.36 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..